We are live on ! Find out more
MCM

MAI Capital Management Portfolio holdings

AUM $17.7B
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+18.87%
3 Year Est. Return
+66.19%
5 Year Est. Return
+78.14%
10 Year Est. Return
+268.52%
AUM
$16.1B
AUM Growth
+$1.58B
Cap. Flow
+$603M
Cap. Flow %
3.76%
Top 10 Hldgs %
26.5%
Holding
4,178
New
198
Increased
1,131
Reduced
1,405
Closed
367

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$20.4M
2
NVDA icon
NVIDIA
NVDA
+$15.5M
3
AVGO icon
Broadcom
AVGO
+$11.9M
4
NFLX icon
Netflix
NFLX
+$11.9M
5
SHW icon
Sherwin-Williams
SHW
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 13.73%
2 Financials 6.31%
3 Healthcare 4.54%
4 Communication Services 4.3%
5 Consumer Discretionary 4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
2451
LKQ Corp
LKQ
$6.38B
$17.9K ﹤0.01%
587
+26
+5% +$854
VKI icon
2452
Invesco Advantage Municipal Income Trust II
VKI
$403M
$17.9K ﹤0.01%
2,042
SLRC icon
2453
SLR Investment Corp
SLRC
$711M
$17.9K ﹤0.01%
1,170
REZI icon
2454
Resideo Technologies
REZI
$3.1B
$17.9K ﹤0.01%
414
-88
-18% -$2.75K
NTB icon
2455
Bank of N.T. Butterfield & Son
NTB
$2.51B
$17.9K ﹤0.01%
416
-92
-18% -$4.15K
NBIX icon
2456
Neurocrine Biosciences
NBIX
$15.3B
$17.8K ﹤0.01%
127
-201
-61% -$27.2K
PHK
2457
PIMCO High Income Fund
PHK
$865M
$17.7K ﹤0.01%
3,550
PI icon
2458
Impinj
PI
$5.46B
$17.7K ﹤0.01%
98
XYLD icon
2459
Global X S&P 500 Covered Call ETF
XYLD
$3.28B
$17.7K ﹤0.01%
451
+2
+0.4% +$78
FOLD
2460
DELISTED
Amicus Therapeutics
FOLD
$17.7K ﹤0.01%
2,240
NAVI icon
2461
Navient
NAVI
$867M
$17.6K ﹤0.01%
1,338
+150
+13% +$2.04K
ITEQ icon
2462
Amplify BlueStar Israel Technology ETF
ITEQ
$120M
$17.6K ﹤0.01%
300
TTEK icon
2463
Tetra Tech
TTEK
$9.33B
$17.5K ﹤0.01%
525
-324
-38% -$11.8K
AMRX icon
2464
Amneal Pharmaceuticals
AMRX
$6.02B
$17.5K ﹤0.01%
1,750
IONS icon
2465
Ionis Pharmaceuticals
IONS
$9.28B
$17.5K ﹤0.01%
267
-159
-37% -$7.76K
XSLV icon
2466
Invesco S&P SmallCap Low Volatility ETF
XSLV
$250M
$17.5K ﹤0.01%
377
CBZ icon
2467
CBIZ
CBZ
$2.96B
$17.4K ﹤0.01%
329
-5
-1% -$322
GXO icon
2468
GXO Logistics
GXO
$5.56B
$17.4K ﹤0.01%
329
-67
-17% -$3.44K
IDT icon
2469
IDT Corp
IDT
$1.67B
$17.4K ﹤0.01%
332
DMC
2470
Del Monte Corp
DMC
$1.44B
$17.4K ﹤0.01%
500
MBC icon
2471
MasterBrand
MBC
$1.89B
$17.3K ﹤0.01%
1,316
-36
-3% -$445
ZURA icon
2472
Zura Bio
ZURA
$540M
$17.3K ﹤0.01%
4,000
INSM icon
2473
Insmed
INSM
$27.6B
$17.3K ﹤0.01%
120
+96
+400% +$11.8K
FLJP icon
2474
Franklin FTSE Japan ETF
FLJP
$4.14B
$17.3K ﹤0.01%
500
NERD icon
2475
Roundhill Video Games ETF
NERD
$15.7M
$17.3K ﹤0.01%
616

Similar funds

MAI Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, MAI Capital Management held 4,178 positions worth $16.1B, up 11% from $14.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MAI Capital Management deployed $603M of net new capital in Q3 2025, opening 198 new positions and adding to 1,131 existing holdings. Its largest new stake was Natixis Loomis Sayles Focused Growth ETF: 228,054 shares worth $10.1M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Applovin, an estimated $20.4M trimmed.

  • MAI Capital Management's largest Q3 2025 buy was Natixis Loomis Sayles Focused Growth ETF: 228,054 shares worth $10.1M.
  • MAI Capital Management added most to Apple in Q3 2025, an estimated $29.6M increase.
  • MAI Capital Management's biggest Q3 2025 reduction was Applovin, cutting an estimated $20.4M.
  • MAI Capital Management fully exited Ansys in Q3 2025, selling an estimated $5.33M.
  • MAI Capital Management's ten largest holdings make up 26% of its $16.1B portfolio in Q3 2025.
  • MAI Capital Management opened 198 new positions and closed 367 in Q3 2025.
  • MAI Capital Management's portfolio value rose 11% quarter-over-quarter to $16.1B.

Based on MAI Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.